| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/2009 | WO2003099808A8 Substituted heterocyclic compounds and methods of use |
| 02/05/2009 | US20090038024 Cap/sorbs1 and diabetes |
| 02/05/2009 | US20090038022 IGF-1 Novel peptides |
| 02/05/2009 | US20090036822 Electrotransport Agent Delivery Method and Apparatus |
| 02/05/2009 | US20090036821 Iontophoretic Transdermal Delivery of Nicotine Salts |
| 02/05/2009 | US20090036819 Drug eluting ocular implant with anchor and methods thereof |
| 02/05/2009 | US20090036761 Noninvasive measurement of chemical substances |
| 02/05/2009 | US20090036704 Process for Preparing 4-Pentafluorosulfanylbenzoylguanidines |
| 02/05/2009 | US20090036682 Crystalline form of 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; used in the treatment of CNS and other disorders |
| 02/05/2009 | US20090036680 Salts of hmg-coa reductase inhibitors and use thereof |
| 02/05/2009 | US20090036675 New process for production of oxabispidines |
| 02/05/2009 | US20090036546 Medicinal Oil Compositions, Preparations, and Applications Thereof |
| 02/05/2009 | US20090036545 Skin appearance through gene manipulation |
| 02/05/2009 | US20090036544 Methods and compositions for inhibiting the proliferation of prostate cancer cells |
| 02/05/2009 | US20090036542 Hydroquinone Long-Chain Derivative and/or Phenoxy Long-Chain Derivative and Pharmaceutical Comprising Same |
| 02/05/2009 | US20090036541 Applicator and chemical combination for better topical anesthesia |
| 02/05/2009 | US20090036540 Guanylhydrazones in Methods of Treatment or Diagnosis as Modulators of Signal Transduction |
| 02/05/2009 | US20090036539 Stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaethesia, and method for manufacturing said composition |
| 02/05/2009 | US20090036538 Treatment methods using triaryl methane compounds |
| 02/05/2009 | US20090036537 Aromatic triamide-lanthanide complexes |
| 02/05/2009 | US20090036536 Biphenyl compound selective agonists of gamma RAR receptors |
| 02/05/2009 | US20090036535 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 02/05/2009 | US20090036534 Method Of Synthesizing S-Allyl-Cysteine Analogues And Their Therapeutic Application In Treating Myocardial Infarction |
| 02/05/2009 | US20090036533 Antibacterial agent comprising 7, 10-dihydroxy-8(e)-octadecenoic acid |
| 02/05/2009 | US20090036532 DHA Enrichment Process |
| 02/05/2009 | US20090036531 Method for treatment of onychomycosis |
| 02/05/2009 | US20090036530 Crystalline acid of lipoxin A4 analogs and method of making |
| 02/05/2009 | US20090036529 Therapeutic agent for functional brain disease |
| 02/05/2009 | US20090036528 Multifunctional and combinational application of aspartame and or futhan |
| 02/05/2009 | US20090036527 Therapeutic Application Of Leonurine In Treating Cardiomyopathy |
| 02/05/2009 | US20090036526 Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate |
| 02/05/2009 | US20090036525 Non-Natural Amino Acid Derivatives |
| 02/05/2009 | US20090036524 Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kappab |
| 02/05/2009 | US20090036523 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 02/05/2009 | US20090036522 Tablet Containing Hardly Soluble Active Ingredient |
| 02/05/2009 | US20090036521 Process for Production of Optically Active Amine Derivatives |
| 02/05/2009 | US20090036520 Combinations of vasoprotective agents and formulations containing them |
| 02/05/2009 | US20090036519 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/05/2009 | US20090036518 Pharmaceutical composition containing flavonoids |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036516 Compounds for treating metabolic syndrome |
| 02/05/2009 | US20090036515 Method for treating colonic viscerosensitivity and spasticity |
| 02/05/2009 | US20090036514 Therapeutic effects of Bryostatins, Bryologs, and other related substances on Ischemia/stroke-induced memory impairment and brain injury |
| 02/05/2009 | US20090036513 Antiviral Drugs for Treatment of Arenavirus Infection |
| 02/05/2009 | US20090036511 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 02/05/2009 | US20090036510 P-3-(trifluoromethyl)-5-(p-tolyl)pyrazol-1-yl)benzenesulonylaminooxy- compounds; more effective than celecoxib and have fewer gastrointestinal and cardiovascular side effects; 4-(5-p-methyl-phenyl)-3-trifluoromethyl-pyrazol-1-yl)-benzenesulfonic acid intermediate |
| 02/05/2009 | US20090036508 Amino indazole derivatives |
| 02/05/2009 | US20090036507 Bis (cyanophenyl) methyl-triazole for use in prevention of breast cancer |
| 02/05/2009 | US20090036506 5-Iodotetrazoles |
| 02/05/2009 | US20090036505 Angiotensin II receptor antagonists such as 2-butyl-4-chloro-1-[2'-(1H-tetrazol-5-yl)1,1'-biphenyl-methyl]imidazole-5-carboxylic acid, pivaloyloxymethyl ester, used as hypotensive agents |
| 02/05/2009 | US20090036504 2-Aminoethoxyacetic Acid Derivatives and Their Use |
| 02/05/2009 | US20090036503 Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 |
| 02/05/2009 | US20090036502 Thiadiazole Compounds and Uses Thereof |
| 02/05/2009 | US20090036501 2-Cyclopenten-1-One Oxime Derivatives Inhibiting Production of TNF-Alpha |
| 02/05/2009 | US20090036500 Use of sustained release oral solid dosage form; side effect reduction of liver damage |
| 02/05/2009 | US20090036498 Fly control method |
| 02/05/2009 | US20090036496 Treatment of Stress Urinary Incontinence and Mixed Urinary Incontinence |
| 02/05/2009 | US20090036495 Combinations Comprising Alpha-2-Delta Ligands and Ep4 Receptor Antagonists |
| 02/05/2009 | US20090036494 Administration of Pharmaceuticals |
| 02/05/2009 | US20090036493 Benzimidazole Derivatives and Their Use for Modulating the GABA Alpha Receptor Complex |
| 02/05/2009 | US20090036492 Novel Cercosporamide Derivative |
| 02/05/2009 | US20090036491 Transdermal pharmaceutical delivery compositions |
| 02/05/2009 | US20090036490 Controlled delivery system |
| 02/05/2009 | US20090036489 Novel Cyclic Aminophenylalkanoic Acid Derivative |
| 02/05/2009 | US20090036488 Recurrence preventive therapeutic agent for psychostimulant-induced psychosis and schizophrenia |
| 02/05/2009 | US20090036487 Combinations |
| 02/05/2009 | US20090036486 3-(2',2'-Dimethylpropanoylamino)tetrahydropyridin-2-one for prevention or treatment of inflammatory disorders, autoimmune diseases |
| 02/05/2009 | US20090036485 Quinoline derivatives |
| 02/05/2009 | US20090036484 Use of Unsaturated Quionoline or Naphtalene Derivatives as Medicaments |
| 02/05/2009 | US20090036483 Quinolinone compounds as 5-ht4 receptor agonists |
| 02/05/2009 | US20090036482 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 02/05/2009 | US20090036481 Novel Azaindole Inhibitors of Mtp and Apob |
| 02/05/2009 | US20090036480 5-Ht7 Receptor Antagonists |
| 02/05/2009 | US20090036479 Method of inhibiting choroidal neovascuarization |
| 02/05/2009 | US20090036478 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 02/05/2009 | US20090036477 Novel 3-Aza-Spiro[5,5]Undec-8-Ene Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors |
| 02/05/2009 | US20090036476 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 02/05/2009 | US20090036475 Pyrazolyl-Pyrimidines as Potassium Channel Modulating Agents and Their Medical Use |
| 02/05/2009 | US20090036474 Quinazoline derivatives for use against cancer |
| 02/05/2009 | US20090036473 Novel quinazolinone derivatives and their medical use |
| 02/05/2009 | US20090036472 Azabicyclo derivatives as anti-inflammatory agents |
| 02/05/2009 | US20090036471 Triazolopyrimidine Derivatives As Glycogen Synthase Kinase 3 Inhibitors |
| 02/05/2009 | US20090036470 Paliperidone derivatives |
| 02/05/2009 | US20090036469 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 02/05/2009 | US20090036468 Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands |
| 02/05/2009 | US20090036467 Alkylsulfonyl-substituted thiazolide compounds |
| 02/05/2009 | US20090036466 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 02/05/2009 | US20090036465 Combination therapy for pulmonary arterial hypertension |
| 02/05/2009 | US20090036464 Treatment Of Posterior Capsule Opacification |
| 02/05/2009 | US20090036463 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/05/2009 | US20090036462 Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones |
| 02/05/2009 | US20090036461 Use of Azabicyclo Hexane Derivatives |
| 02/05/2009 | US20090036460 Crystalline pyridazine compound |
| 02/05/2009 | US20090036459 Melanocortin Type 4 Receptor Agonist Piperidinoylpyrrolidines |
| 02/05/2009 | US20090036458 Endoparasiticidal topical compositions |
| 02/05/2009 | US20090036457 Utilities of olefin derivatives |
| 02/05/2009 | US20090036456 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/05/2009 | US20090036455 Arylpiperazine derivative and use thereof as 5-ht1a receptor ligands |
| 02/05/2009 | US20090036454 Compounds and Uses Thereof |
| 02/05/2009 | US20090036453 Pyrrolopyridazinone Compound |